Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 3 for:    LY2812176
Previous Study | Return to List | Next Study

A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
HealthCare Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01457417
First received: October 18, 2011
Last updated: June 26, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)